Hospitals and research centers around the United States—and around the world—are addressing security, safety and liability concerns by replacing blood irradiators that use cesium-137 with FDA-approved x-ray technology. NTI provides resources to prepare you to join them, with answers to technical questions and information on how to get financial support to take this important step.
Why Take This Step?
The ingredients for a radiological “dirty bomb” – among them, the same isotopes that make life saving blood transfusions and cancer treatments possible – are located at thousands of sites in more than 150 countries.
Experts believe that the probability of a terrorist detonating a dirty bomb is much higher than that of an improvised nuclear weapon. Radical terrorist organizations such as the Islamic State have said they are looking to acquire and use radioactive material in a dirty bomb.
A radioactive dirty bomb could cause billions of dollars of damage due to the costs of evacuation, relocation, and cleanup. A dirty bomb that intentionally spreads cesium-137, a common isotope found in blood irradiators, would have the most devastating consequences.